Beyond supporting its VitaSmart system's US rollout, Bridge to Life also intends to use the funds to expand its portfolio and scale its global operations.

Abbott and Google Health have collaborated to bring ongoing glucose monitoring and AI-driven health guidance to Google Health users.

Zepto's grant from NIAID follows its fungal infection panel's receipt of breakthrough device designation from the FDA in June 2026.

Teledyne Technologies has entered a definitive agreement to purchase Varex Imaging in a cash transaction valued at nearly $1.1bn.

The lion’s share of Alcon’s profits came from its surgical segment at around $1.6bn, indicative of an 8% uptick YoY.

Integer Holdings is to be acquired by an affiliate of investment funds managed by KKR, in an all-cash deal valuing the company at $5.7bn.

Acarix has secured regulatory approval for its CADScor system in the UAE, a step that paves the way for the device's commercial availability.

Collette Health has entered into a partnership with VirtuAlly to provide virtual care programmes for hospitals and health systems.

GlobalData analysts Dr Andrew Thompson and Charlie Whelan will discuss key challenges impacting the diabetes technology supply chain in a webinar on 18 August.

Zimmer released its Q2 financials ahead of market open, prompting its shares on the New York Stock Exchange to rise by over 5% at market open on 5 August.

Resmed highlighted that factors including suspended ventilator sales and ongoing macro uncertainty had contributed to its tempered FY27 outlook.

BlueWind Medical’s Revi Extend, the company’s next-generation urge urinary incontinence (UUI) treatment that extends the implant’s lifespan to 15 years, has secured US Food ...